Meir Retchkiman

Dr. Meir Retchkiman

orcid

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 August 2016 in Aesthetic Plastic Surgery
Verified
Journal Article
Closed access
PDF file
ALAdi Maisel Lotan
Adi Maisel Lotan
MRMeir Retchkiman
Meir Retchkiman
ITIzhak Tuchman
Izhak Tuchman
RBRami Binenboym
Rami Binenboym
YGYoav Gronovich
Yoav Gronovich

4 July 2016 in Burns & Trauma
Verified
Journal Article
Open access
PDF file
YGYoav Gronovich
Yoav Gronovich
ALAdi Maisel Lotan
Adi Maisel Lotan
MRMeir Retchkiman
Meir Retchkiman
Background: Full thickness burns of the chest in childhood are a devastating problem that requires challenging reconstructive options. Integra is a bilaminate artificial dermis composed of shark chondroitin 6-sulfate and bovine collagen. The dermal matrix serves as a scaffold for fibroblasts and endothelial cells. Vascularization of the matrix begins after 2–3 weeks, and eventually, the matrix incorporates with the tissue to create a new dermis. The main advantage of the Integra is that the neodermis is of the same quality as a native dermis. Case presentation: In this case report, we present post-burn breast reconstruction of a 12-year-old girl using Integra, with a long follow-up of 7 years. To the best of our knowledge, there is no published follow-up of breast development after reconstruction with Integra from its beginning point at the age of puberty until after the growing process has terminated. Conclusions: Integra is a reliable reconstructive tool for burned breast. If done before puberty, it can help in getting normal developing tissue with satisfying esthetic results of size, shape and symmetry.

Verified
Journal Article
Open access
PDF file
NSNoa Sabag
Noa Sabag
AYAlexander Yakobson
Alexander Yakobson
MRMeir Retchkiman
Meir Retchkiman
ESEldad Silbertein
Eldad Silbertein
Malignant melanoma is one of the most common cancers in the world. In the disease’s early stages, treatment involves surgery, in advanced stages however, treatment options were once scarce. There has been a paradigm shift in advanced melanoma treatment with the introduction of immunotherapy and targeted therapies. Understanding the molecular pathways and their pathologic counterparts helped identifying specific biomarkers that lead to the development of specific targeted therapies. In this review we briefly present some of these markers and their relevance to melanoma treatment.

1 July 2020 in Annales de Chirurgie Plastique Esthétique
Verified
Journal Article
Closed access
Michel Alain DaninoMichel Alain Danino
Michel Alain Danino
DGD. Giaccone
D. Giaccone
AKA. El Khatib
A. El Khatib
GDG. Dimitropoulos
G. Dimitropoulos
ODO. Doucet
O. Doucet
CBC. Bernier
C. Bernier

1 June 2021 in Annales de Chirurgie Plastique Esthétique
Verified
Journal Article
Closed access
YPY. Papas
Y. Papas
JBJ. Bou-Merhi
J. Bou-Merhi
AOA. Odobescu
A. Odobescu
MRMeir Retchkiman
Meir Retchkiman
Michel Alain DaninoMichel Alain Danino
Michel Alain Danino

1 February 2021 in Annales de Chirurgie Plastique Esthétique
Verified
Journal Article
Closed access
Michel Alain DaninoMichel Alain Danino
Michel Alain Danino
DGD. Giaccone
D. Giaccone
MAM. Abdolraziq
M. Abdolraziq
MRMeir Retchkiman
Meir Retchkiman
LPL.S. Paek
L.S. Paek
JIJ. Iezzoni
J. Iezzoni